About Pesach Tikvah Hope Development Inc.
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Mentoring/peer support; Employment counseling or training
Other Services
Treatment for other addiction disorder
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Social skills development; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Mentoring/peer support; Employment counseling or training
Other Services
Treatment for other addiction disorder
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Social skills development; Suicide prevention services
